Murine Model Imitating Chronic Wound Infections for Evaluation of Antimicrobial Photodynamic Therapy Efficacy

Abstract

It is generally acknowledged that the age of antibiotics could come to an end, due to their widespread, and inappropriate use. Particularly for chronic wounds alternatives are being thought. Antimicrobial Photodynamic Therapy (APDT) is a potential candidate, and while approved for some indications, such as periodontitis, chronic sinusitis and other niche indications, its use in chronic wounds is not established. To further facilitate the development of APDT in chronic wounds we present an easy to use animal model exhibiting the key hallmarks of chronic wounds, based on full-thickness skin wounds paired with an optically transparent cover. The moisture-retaining wound exhibited rapid expansion of pathogen colonies up to 8 days while not jeopardizing the host survival. Use of two bioluminescent pathogens; methicillin resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa permits real time monitoring of the pathogens. The murine model was employed to evaluate the performance of four different photosensitizers as mediators in Photodynamic Therapy. While all four photosensitizers, Rose Bengal, porphyrin TMPyP, New Methylene Blue, and TLD1411 demonstrated good to excellent antimicrobial efficacy in planktonic solutions at 1 to 50 μM concentrations, whereas in in vivo the growth delay was limited with 24–48 h delay in pathogen expansion for MRSA, and we noticed longer growth suppression of P. aeruginosa with TLD1411 mediated Photodynamic Therapy. The murine model will enable developing new strategies for enhancement of APDT for chronic wound infections.

Antimicrobial blue light photoinactivation of Pseudomonas aeruginosa: Quorum sensing signaling molecules, biofilm formation and pathogenicity

“…To elevate aBL as an advantageous approach over conventional antibiotics, the anti‐biofilm and anti‐pathogenic efficacy of aBL must be determined using an in vivo infection model. Many in vivo models of bacterial infection exist, including Arabidopsis thaliana , Drosophila melanogaster mice and rat models . One promising organism is C. elegans .…”

A murine model of Staphylococcus aureus infected chronic diabetic wound: A new tool to develop alternative therapeutics

“…However, this requires the mandatory use of genetically modified LIGHT−/− mice. Another study has defined as chronic a wound that did not heal following an infection associated with the application of Tegaderm . Nevertheless, the measurements made during this study never exceeded 8 days after inoculation, a time period that we consider too short for a chronic wound model.…”

In situ Treatment With Novel Microbiocide Inhibits Methicillin Resistant Staphylococcus aureus in a Murine Wound Infection Model

“…Further this decreased the number of mice needed for infection studies as it eliminated the need to sacrifice mice at specific time points for bacterial burdens. The use of bioluminescent bacteria to track wound infections has been growing in popularity and become a more common practice (Guo et al, 2013;Fila et al, 2016;Agostinho Hunt et al, 2017). Many wound infection studies, however, lack the use of silicon splints.…”